“Adenosine Monophosphate-Activated Protein Kinase (AMPK) As a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations ”. The Review of Diabetic Studies , vol. 6, no. 1, Aug. 2023, https://diabeticstudies.org/index.php/RDS/article/view/252.